Comparing Number of Injection Sites of In-office Intravesical Onabotulinumtoxin A Treatments for Overactive Bladder: A Randomized Controlled Trial
NCT05157295
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
100
Enrollment
OTHER
Sponsor class
Conditions
Overactive Bladder Syndrome
Overactive Bladder
Interventions
DRUG:
OnabotulinumtoxinA
Sponsor
Augusta University